References: 1. ZYLET [prescribing information]. Tampa, FL: Bausch & Lomb Incorporated; 2013. 2. Guillon M, Maissa C, Pouliquen P, Delval L. Effect of povidone 2% preservative-free eye drops on contact lens wearers with computer visual syndrome: pilot study. Eye Contact Lens . 2004;30(1):34-39. 3. Reed KK. How to manage bacterial eye infections. Review of Optometry . May 2011. http:///continuing_education/tabviewtest/lessonid/107608/dnnprintmode/true/skinsrc/. Accessed January 7, 2014. 4. Contact Lens-Induced Acute Red Eye (CLARE). Living Library. Association of Optometric Contact Lens Educators. http:///livingL/. Accessed January 3, 2014. 5. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf . 2009;7(2 suppl):S1-S14. 6. Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev . 2012;5:CD005556. 7. Blepharitis. American Optometric Association. http:///patients-and-public/eye-and-vision-problems/glossary-of-eye-and-vision-conditions/blepharitis?sso=y. Accessed July 7, 2015.
The Female Panel of five hormones may highlight imbalances that can contribute to a number of different health conditions. Low levels of estrogens may contribute to bone loss, fatigue, heart disease, hot flashes, sleep disturbances, vaginal dryness and depression. Low testosterone may also contribute to bone loss, depression, fatigue, heart disease and vaginal dryness. High estrogens or low progesterone may be a factor in anxiety symptoms, weight gain and breast cancer risk. Fatigue often accompanies hormone imbalance and is frequently observed in postmenopausal women. Hormone imbalance may also be a feature of metabolic syndrome.
Testosterone can be administered parenterally , but it has more irregular prolonged absorption time and greater activity in muscle in enanthate , undecanoate , or cypionate ester form. These derivatives are hydrolyzed to release free testosterone at the site of injection; absorption rate (and thus injection schedule) varies among different esters, but medical injections are normally done anywhere between semi-weekly to once every 12 weeks. A more frequent schedule may be desirable in order to maintain a more constant level of hormone in the system.  Injectable steroids are typically administered into the muscle, not into the vein, to avoid sudden changes in the amount of the drug in the bloodstream. In addition, because estered testosterone is dissolved in oil, intravenous injection has the potential to cause a dangerous embolism (clot) in the bloodstream.